FREE WEBINAR: Psilocybin-assisted Therapy for End-of-Life Distress · Mind Medicine Australia
Mind Medicine Australia logo Menu

FREE WEBINAR: Psilocybin-assisted Therapy for End-of-Life Distress

With Dr Gabby Agin-Liebes (USA)

Date: Wed 28 April 2021 @ 12:00pm
Location: Online

Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

Psilocybin has been being researched by various institutions, including NYU and John Hopkins, for its potential therapeutic benefit to combat end-of-life anxiety due to terminal illness and cancer. The study results are fascinating:

At the 6.5-month follow-up, psilocybin was associated with enduring anxiolytic and anti-depressant effects (approximately 60–80% of participants continued with clinically significant reductions in depression or anxiety), sustained benefits in existential distress and quality of life, as well as improved attitudes towards death. The psilocybin-induced mystical experience mediated the therapeutic effect of psilocybin on anxiety and depression.

In this presentation, Gabby Agin-Liebes, a co-author of the psilocybin study quoted above and a PhD student studying clinical psychology, we explore:

  • Formation of the NYU study
  • Gabby’s role in the study
  • How volunteers were selected
  • Inclusion and admission criteria
  • Study results
  • Can psilocybin help those who are facing death?
  • Current research that Gabby is part of and co-leading
  • How to get involved in the psychedelic field
  • Dreams and visions for the future of psychedelics and psychedelic research

WEBINAR SESSION

Date: Wednesday 28 April 2021
Time: 11:55am for 12:00pm start – 1:15pm (incl Q&A) (AEST)
The presentation WILL BEGIN AT 12:00pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation, there will be a Q & A panel with Dr Gabby Agin-Liebes and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

The Presenters

Dr Gabby Agin-Liebes (USA)

PH.D

Gabby Agin-Liebes, PhD is a clinical psychologist with 10 years of experience working as a therapist and investigator on academic trials with psilocybin-assisted therapy at New York University, Yale and UC San Francisco (UCSF). Her research has applied quantitative and qualitative methodologies within psilocybin-assisted and mindful self-compassion-based interventions to treat substance use and trauma-based disorders. She is currently a National Institutes of Health-funded research fellow at UCSF studying novel interventions for treating opioid addiction and chronic pain that target dysregulated emotion regulation and attentional bias processes. She is the lead author on a paper published earlier this year, and featured in several news outlets, which found that psilocybin-therapy led to sustained clinical remission from depression and anxiety in individuals with cancer up to 4.5 years later.

Tania de Jong AM

LL.B (Hons), GradDipMus

Founder & Deputy Chair of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 3 charities including Creative Universe, Creativity Australia and With One Voice, Creative Innovation Global, Mind Medicine Australia, Dimension5, MTA Entertainment & Events, Pot-Pourri and The Song Room.

She works across the public, private, creative and community sectors and is passionate about mental health, innovation, diversity and inclusion.  Tania speaks and sings around the world as a soloist and with her group Pot-Pourri releasing eleven albums. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global.

She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018. Tania’s TED Talk ‘How Singing Together Changes The Brain’ has sparked international interest. Tania’s mission is to change the world, one voice at a time!

Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×